Skip to content

Clinical trials

Observational Multiple Sclerosis, Relapsing-Remitting trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Observational Country / region: United States Clear all

53 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20072
20082
20093
20112
20122
20132
20141
20152
20164
20172
20184
20193
20216
20223
20236
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Unknown status4
Recruiting4
Terminated4
Active, not recruiting3
Suspended2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Biogen3
Kessler Foundation3
Novartis Pharmaceuticals3
Novartis2
Providence Health & Services2
University of California, San Francisco2
University of Louisville2
University of Southern California2
University of Virginia2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting53
Multiple Sclerosis28
Multiple Sclerosis, Chronic Progressive12
Arthritis, Rheumatoid2
Demyelinating Diseases2
Neoplasms2
Nervous System Diseases2
Neuromyelitis Optica2
Psoriasis2
Acne Vulgaris1

Trials

Showing 1 to 25 of 53. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.